KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference

MAHWAH, N.J.–(BUSINESS WIRE)–KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the company will participate in the Canaccord Genuity 45th Annual Growth Conference on August 13th, 2025. KORU Medical’s management is scheduled to present at the Canaccord Genuity 45th An

administrator

Related Articles